60 Degrees Pharmaceuticals, Inc.
SXTP
$1.63
-$0.08-4.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.37M | -7.97M | -7.82M | -10.25M | -7.95M |
| Total Depreciation and Amortization | 82.90K | 75.20K | 67.10K | 58.40K | 63.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 438.80K | 914.80K | 1.30M | 3.83M | 2.04M |
| Change in Net Operating Assets | -5.50K | 186.80K | 82.50K | 257.60K | 192.60K |
| Cash from Operations | -6.85M | -6.79M | -6.37M | -6.11M | -5.65M |
| Capital Expenditure | -139.90K | -60.00K | -63.80K | -106.50K | -103.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 394.70K | 1.68M | -34.20K | -70.40K | -1.79M |
| Cash from Investing | 254.90K | 1.62M | -97.90K | -176.80K | -1.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.46M | 6.00M | 6.86M | 6.87M | 7.05M |
| Repurchase of Common Stock | -18.00K | -18.00K | -18.00K | -18.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 5.90K | 0.00 | 0.00 |
| Cash from Financing | 6.44M | 5.98M | 6.85M | 6.85M | 7.05M |
| Foreign Exchange rate Adjustments | 7.10K | 6.50K | 7.10K | -8.60K | 500.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -149.40K | 815.00K | 390.30K | 556.80K | -483.10K |